Disease/Infection News

RSS

New edition of WHO Essential Medicines List includes new treatments for hepatitis C, cancers and multi-drug TB

WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others. The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health impact globally.

8 May 2015

LSTM scientists one step closer to understanding why HAP increases risk of pneumonia

Scientists at LSTM have come a step closer to understanding why people exposed to household air pollution (HAP) are at higher risk of lung infections such as pneumonia and tuberculosis.

8 May 2015

WHO calls on experts, social media to follow best practices in naming new human infectious diseases

WHO today called on scientists, national authorities and the media to follow best practices in naming new human infectious diseases to minimize unnecessary negative effects on nations, economies and people.

8 May 2015

Full range of Lab M media for detection and isolation of Listeria shown together for the first time

The document, ‘Listeria solutions… whatever your method’, clearly shows that whichever testing method users subscribe to, whatever the lab size, and whether they prefer dehydrated culture media...

8 May 2015

Discovery opens up new avenue for development of potential therapies to treat, prevent malaria

Scientists have identified a protein on the surface of human red blood cells that serves as an essential entry point for invasion by the malaria parasite. This discovery opens up a promising new avenue for the development of therapies to treat and prevent malaria.

8 May 2015

WHO issues best practices for naming new human infectious diseases

The World Health Organization (WHO) today called on scientists, national authorities and the media to follow best practices in naming new human infectious diseases to minimize unnecessary negative effects on nations, economies and people...

8 May 2015

Natural substance could help people avoid cavities, gum disease

Arginine, a common amino acid found naturally in foods, breaks down dental plaque, which could help millions of people avoid cavities and gum disease, researchers at the University of Michigan and Newcastle University have discovered.

8 May 2015

WHO moves to improve access to lifesaving medicines for hepatitis C, Drug-resistant TB and cancers

The World Health Organization (WHO) today published the new edition of its Model List of Essential Medicines) which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others...

8 May 2015

Bamboo could increase spread of hantavirus, warns WSU ecologist

Washington State University researchers say the popularity of bamboo landscaping could increase the spread of hantavirus, with the plant's prolific seed production creating a population boom among seed-eating deer mice that carry the disease.

8 May 2015

New research could help predict outbreaks of West Nile virus disease in the U.S.

New research has identified correlations between weather conditions and the occurrence of West Nile virus disease in the United States, raising the possibility of being able to better predict outbreaks.

8 May 2015

Pain management webinar addresses fibromyalgia, "the invisible disease"

Topical BioMedics is hosting its free monthly pain management webinar on Tuesday, May 12th, focusing on the topic “What You need to Know about Fibromyalgia.” The webinar, which is free and open to the public, will be streamed live from 12pm to 1pm, then archived and accessible on demand 24/7...

7 May 2015

WHO committed to helping Nepal deliver health care to its citizens, says WHO South-East Asia Regional Director

The World Health Organization is committed to supporting Nepal’s health system to deliver life-saving and essential services to its people and build back resilient health facilities that will be safe in emergencies...

7 May 2015

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

7 May 2015

Smartphone checks blood for parasitic disease

New Smartphone technology has been developed that can detect and count wriggling parasitic worms in a drop of blood...

7 May 2015

Myriad to present new clinical data on Prolaris® at the AUA 2015 annual meeting

Myriad Genetics, Inc. announced it will present three studies that demonstrate the value of the Prolaris test for physicians and their patients at the 2015 American Urological Association (AUA) Annual Meeting being held May 15 to 19 in New Orleans, La...

7 May 2015

Hepatitis C common among HIV-positive patients in sub-Saharan Africa

A new study has found high levels of infection with hepatitis C (HCV) across Africa, particularly in people infected with HIV...

7 May 2015

Adelaide researchers identify target for developing new antibiotics against disease-causing bacteria

University of Adelaide researchers have discovered a target for the development of completely new antibiotics against disease-causing bacteria.

7 May 2015

Treatment significantly reduces risk of CDI recurrence

Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a study in the May 5 issue of JAMA.

7 May 2015

Investigational three-drug combination clears hepatitis C in 93% of patients with liver cirrhosis

A 12-week dose of an investigational three-drug hepatitis C combination cleared the virus in 93 percent of patients with liver cirrhosis who hadn't previously been treated, according to a study in the May 5, 2015, issue of The Journal of the American Medical Association.

7 May 2015

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the patient's gastrointestinal tract, and several other body sites.

7 May 2015

Disease/Infection News

New edition of WHO Essential Medicines List includes new treatments for hepatitis C, cancers and multi-drug TB

LSTM scientists one step closer to understanding why HAP increases risk of pneumonia

WHO calls on experts, social media to follow best practices in naming new human infectious diseases

Full range of Lab M media for detection and isolation of Listeria shown together for the first time

Discovery opens up new avenue for development of potential therapies to treat, prevent malaria

WHO issues best practices for naming new human infectious diseases

Natural substance could help people avoid cavities, gum disease

WHO moves to improve access to lifesaving medicines for hepatitis C, Drug-resistant TB and cancers

Bamboo could increase spread of hantavirus, warns WSU ecologist

New research could help predict outbreaks of West Nile virus disease in the U.S.

Pain management webinar addresses fibromyalgia, "the invisible disease"

WHO committed to helping Nepal deliver health care to its citizens, says WHO South-East Asia Regional Director

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

Smartphone checks blood for parasitic disease

Myriad to present new clinical data on Prolaris® at the AUA 2015 annual meeting

Hepatitis C common among HIV-positive patients in sub-Saharan Africa

Adelaide researchers identify target for developing new antibiotics against disease-causing bacteria

Treatment significantly reduces risk of CDI recurrence

Investigational three-drug combination clears hepatitis C in 93% of patients with liver cirrhosis

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News